Pharmafile Logo

Dedicated

Webinar: Prescription Rationale: Physician Research via an iPhone App

This webinar explores the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription.

Inizio

Merrill Brink languages

Seven tips to get the most out of your relationships with translation partners

The most effective translation and localization strategies align the best people, processes and technology to deliver multilingual content.

Merrill Brink International

Five steps to choosing the most effective language services partner

Life Sciences Translations – Five steps to choosing the most effective language services partner

Companies in the life sciences industry face a particularly tough set of challenges in bringing products to the global marketplace, not least of which is delivering multilingual content.

Merrill Brink International

- PMLiVE

EMA gives details of new ‘future-proof’ structure

Will divide into four key areas covering R&D, medicines evaluation, business support and pharmacovigilance

- PMLiVE

Dendreon’s cancer vaccine wins EU approval

Provenge approved for use in prostate cancer three years after US recommendation

- PMLiVE

Malcolm Badger joins emotive

Takes up role as creative director after five years with Havas Life

China flag thumb

Novartis’ Alcon unit diverted trial money for bribes, claims paper

21st Century Business Herald publishes more allegations of corruption in China

- PMLiVE

NICE demands more data for Sanofi’s oral MS drug

UK body won't recommend Aubagio for NHS use based on current information

- PMLiVE

‘Biomedical Facebook’ launches to speed up cancer research

Europe's Granatum.org aims to connect pharma, academia and other research bodies

- PMLiVE

This month in 2010: How one woman helped prevent a health crisis in the US

The FDA's Frances Oldham Kelsey honoured for her work to prevent the use of thalidomide

- PMLiVE

Wim Goemaere appointed CFO at Bone Therapeutics

He joins from agricultural biotech firm Devgen

Sanofi reception

Sanofi wins EU approval for second MS drug in a month

EC approves Lemtrada weeks after Aubagio gets greenlight

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links